Quantbot Technologies’s Royalty Pharma RPRX Stock Holding History

Quantbot Technologies’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.5M	Buy	80,193 +51,506	+180%	+$2.68M	0.18%	145
2026 Q1	$1.38M	Sell	28,687 -75,369	-72%	-$3.3M	0.06%	491
2025 Q4	$4.02M	Buy	104,056 +24,095	+30%	+$919K	0.13%	236
2025 Q3	$2.82M	Buy	+79,961	New	+$2.89M	0.08%	407
2023 Q3	–	Sell	-25,626	Closed	-$788K	–	1900
2023 Q2	$788K	Buy	25,626 +19,651	+329%	+$666K	0.05%	512
2023 Q1	$215K	Buy	5,975 +5,170	+642%	+$192K	0.02%	887
2022 Q4	$31.8K	Sell	805 -184	-19%	-$7.68K	﹤0.01%	1380
2022 Q3	$39K	Buy	+989	New	+$42.2K	﹤0.01%	1286
2022 Q1	–	Sell	-9,601	Closed	-$382K	–	1993
2021 Q4	$382K	Buy	+9,601	New	+$373K	0.03%	598

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's RPRX Position: Q2 2026 in Review

Quantbot Technologies increased its Royalty Pharma (RPRX) stake by 180% in Q2 2026, buying an estimated $2.68M and bringing the position to 80,193 shares worth $4.5M. The position accounts for 0.18% of the portfolio, ranked #145.

Quantbot Technologies first reported a position in RPRX in Q4 2021 and has held it in 9 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Quantbot Technologies held 80,193 shares of Royalty Pharma worth $4.5M as of Q2 2026.
Quantbot Technologies bought 51,506 Royalty Pharma shares in Q2 2026, an estimated $2.68M.
Royalty Pharma made up 0.18% of Quantbot Technologies's portfolio in Q2 2026, its #145 holding.
Quantbot Technologies first reported a position in Royalty Pharma in Q4 2021 and has held it in 9 quarters since.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.